These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19229073)

  • 21. Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA.
    Kellar KE; Fujii DK; Gunther WH; Briley-Saebø K; Bjornerod A; Spiller M; Koenig SH
    Acad Radiol; 2002 May; 9 Suppl 1():S34-7. PubMed ID: 12019889
    [No Abstract]   [Full Text] [Related]  

  • 22. MR relaxivity measurement of iron oxide nano-particles for MR lymphography applications.
    Firouznia K; Amirmohseni S; Guiti M; Amanpour S; Baitollahi A; Kharadmand AA; Mohagheghi MA; Oghabian MA
    Pak J Biol Sci; 2008 Feb; 11(4):607-12. PubMed ID: 18817134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerotic imaging using 4 types of superparamagnetic iron oxides: new possibilities for mannan-coated particles.
    Tsuchiya K; Nitta N; Sonoda A; Otani H; Takahashi M; Murata K; Shiomi M; Tabata Y; Nohara S
    Eur J Radiol; 2013 Nov; 82(11):1919-25. PubMed ID: 24001603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of atherosclerotic plaques with MRI at 3 T using ultrasmall superparamagnetic particles of iron oxide.
    Priest AN; Ittrich H; Jahntz CL; Kooijman H; Weber C; Adam G
    Magn Reson Imaging; 2006 Dec; 24(10):1287-93. PubMed ID: 17145399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
    Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
    PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles.
    Dardzinski BJ; Schmithorst VJ; Holland SK; Boivin GP; Imagawa T; Watanabe S; Lewis JM; Hirsch R
    Magn Reson Imaging; 2001 Nov; 19(9):1209-16. PubMed ID: 11755731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
    Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
    Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy.
    Radermacher KA; Beghein N; Boutry S; Laurent S; Vander Elst L; Muller RN; Jordan BF; Gallez B
    Invest Radiol; 2009 Jul; 44(7):398-404. PubMed ID: 19554667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The possibility of visualizing TGF-β1 expression in ApoE
    Xia M; Wu F; Yang Y; Lu W; Song M; Ma Z
    Acta Radiol; 2024 Jan; 65(1):99-105. PubMed ID: 36760069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis.
    Tang TY; Moustafa RR; Howarth SP; Walsh SR; Boyle JR; Li ZY; Baron JC; Gillard JH; Warburton EA
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):53-5. PubMed ID: 18396074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Carotid Plaque Inflammation in Diabetic and Nondiabetic Patients-An Exploratory Ultrasmall Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging Study.
    Usman A; Patterson AJ; Sadat U; Tang TY; Graves MJ; Gillard JH
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):858-862. PubMed ID: 27881291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
    Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
    Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
    J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three types of physical measurements needed to characterize iron oxide nanoparticles for MRI and MRA: magnetization, relaxometry, and light scattering.
    Koenig SH; Kellar KE; Fujii DK; Gunther WH; Briley-Saebø K; Spiller M
    Acad Radiol; 2002 May; 9 Suppl 1():S5-10. PubMed ID: 12019893
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits.
    Ruehm SG; Corot C; Vogt P; Cristina H; Debatin JF
    Acad Radiol; 2002 May; 9 Suppl 1():S143-4. PubMed ID: 12019852
    [No Abstract]   [Full Text] [Related]  

  • 38. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.
    Ruehm SG; Corot C; Vogt P; Kolb S; Debatin JF
    Circulation; 2001 Jan; 103(3):415-22. PubMed ID: 11157694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron oxides as MR imaging contrast agents.
    Fahlvik AK; Klaveness J; Stark DD
    J Magn Reson Imaging; 1993; 3(1):187-94. PubMed ID: 8428086
    [No Abstract]   [Full Text] [Related]  

  • 40. Dual-energy CT imaging of atherosclerotic plaque using novel ultrasmall superparamagnetic iron oxide in hyperlipidemic rabbits.
    Sato H; Fujimoto S; Kawaguchi YO; Nozaki YO; Tomizawa N; Kogure Y; Minamino T
    Acta Radiol; 2023 Apr; 64(4):1718-1724. PubMed ID: 36226361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.